C
쓰리빌리언
394800KOSDAQ자연과학 및 공학 연구개발업48.3 / 100
Reference Date: 2026-04-13
Financial Score14.0 / 40
News Sentiment14.3 / 25
Momentum6.0 / 20
Disclosure14.0 / 15
AI Analysis: PBR raises overvaluation concerns, ROE is below the industry average. Plunged 20.4% over the past month, and news sentiment is positive.
Company InformationBased on 2025 Annual Report
Business Overview
3billion is a company leading the diagnosis and development of treatments for rare diseases using AI-based genome interpretation technology, offering genetic testing services such as whole genome and whole exome sequencing. As of 2025, it generates revenue in 75 countries, with 67.4% of sales coming from overseas, and has launched its own genetic variant interpretation software 'GEBRA' as a SaaS product.
Number of Employees
196people
Average Salary
67.2M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 120.074.0Point
PBR
15.30Industry Average 3.820.0Point
4.0x industry avg (risky)
ROE
-20.87Industry Average -32.113.5Point
Below industry avg
Debt Ratio
11.50Industry Average 7.520.5Point
1.5x industry avg (risky)
Trend 2024~20256.0 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲102.8% (1-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲20.6% (1-year basis)
ROE Trend
0.0 / 4
Avg ROE -26.8% (improving, 2yr)
Detailed News Sentiment
10 totalPositive 2Neutral 3Negative 0Average Sentiment Score 64
- Neutral
- Neutral
- Neutral
Detailed Momentum
52-week position5.0Point
52w mid range (43%)
Current 11,370Won52-week high 18,80052-week low 5,600
1-month return0.0Point
1m -20.43% (strong drop)
Volume trend1.0Point
Volume decreasing
Detailed Disclosure
7 totalPositive 2Neutral 5Negative 0
- Positive단일판매ㆍ공급계약체결(자율공시)2026-04-09
- Neutral주식등의대량보유상황보고서(약식)2026-04-01
- Neutral정기주주총회결과2026-03-31
- Neutral주식매수선택권부여에관한신고2026-03-31
- Neutral사업보고서 (2025.12)2026-03-23